CETIRIZINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE was reported 167970 times

These side effects are most commonly reported by patients taking CETIRIZINE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 22109
1 FATIGUE 19252
2 PAIN 16194
3 OFF LABEL USE 14620
4 RASH 13756
5 PRURITUS 12979
6 HEADACHE 12972
7 NAUSEA 12171
8 DYSPNOEA 11448
9 ABDOMINAL DISCOMFORT 10897
10 ALOPECIA 10742
11 ARTHRALGIA 10664
12 DIARRHOEA 10209
13 HYPERSENSITIVITY 10141
14 RHEUMATOID ARTHRITIS 9522
15 SYSTEMIC LUPUS ERYTHEMATOSUS 9013
16 SWELLING 8942
17 DIZZINESS 8770
18 PEMPHIGUS 8677
19 URTICARIA 8641
20 VOMITING 8560
21 PYREXIA 8400
22 GLOSSODYNIA 8273
23 JOINT SWELLING 7963
24 INFUSION RELATED REACTION 7850
25 CONDITION AGGRAVATED 7585
26 PRODUCT USE ISSUE 7584
27 MALAISE 7574
28 ARTHROPATHY 7330
29 HAND DEFORMITY 7177
30 PRODUCT USE IN UNAPPROVED INDICATION 7110
31 WOUND 7040
32 HEPATIC ENZYME INCREASED 6822
33 CONTRAINDICATED PRODUCT ADMINISTERED 6796
34 DRUG INTOLERANCE 6777
35 WEIGHT INCREASED 6746
36 NASOPHARYNGITIS 6631
37 PERICARDITIS 6580
38 SINUSITIS 6578
39 MATERNAL EXPOSURE DURING PREGNANCY 6485
40 DISCOMFORT 6446
41 PERIPHERAL SWELLING 6349
42 INSOMNIA 6314
43 SYNOVITIS 6284
44 HYPERTENSION 6239
45 ASTHENIA 5808
46 ANXIETY 5679
47 INFECTION 5650
48 PNEUMONIA 5577
49 ABDOMINAL PAIN UPPER 5573
50 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5527
51 CONFUSIONAL STATE 5485
52 BLISTER 5399
53 DRUG HYPERSENSITIVITY 5249
54 ASTHMA 5176
55 COUGH 5135
56 DUODENAL ULCER PERFORATION 5115
57 HELICOBACTER INFECTION 5082
58 SOMNOLENCE 5019
59 PAIN IN EXTREMITY 4968
60 GENERAL PHYSICAL HEALTH DETERIORATION 4936
61 STOMATITIS 4788
62 HYPOAESTHESIA 4778
63 LOWER RESPIRATORY TRACT INFECTION 4764
64 DEPRESSION 4743
65 THERAPEUTIC PRODUCT EFFECT DECREASED 4597
66 IMPAIRED HEALING 4596
67 IRRITABLE BOWEL SYNDROME 4543
68 FOLLICULITIS 4469
69 WEIGHT DECREASED 4366
70 TREATMENT FAILURE 4355
71 GASTROINTESTINAL DISORDER 4326
72 DECREASED APPETITE 4283
73 WHEEZING 4246
74 CONTUSION 4242
75 CHEST PAIN 4122
76 MUSCULOSKELETAL STIFFNESS 4108
77 INTENTIONAL PRODUCT USE ISSUE 4071
78 TYPE 2 DIABETES MELLITUS 4028
79 ABDOMINAL PAIN 3986
80 PSORIATIC ARTHROPATHY 3985
81 MUSCLE INJURY 3947
82 FALL 3903
83 BACK PAIN 3864
84 SLEEP DISORDER 3757
85 MUSCLE SPASMS 3743
86 INJURY 3736
87 BLOOD CHOLESTEROL INCREASED 3730
88 ILL-DEFINED DISORDER 3728
89 MOBILITY DECREASED 3721
90 MIGRAINE 3674
91 FIBROMYALGIA 3565
92 PARAESTHESIA 3519
93 PRODUCT DOSE OMISSION ISSUE 3511
94 FEELING ABNORMAL 3505
95 DRY MOUTH 3473
96 RHEUMATOID FACTOR POSITIVE 3472
97 ERYTHEMA 3463
98 MEMORY IMPAIRMENT 3351
99 LIVER INJURY 3181
100 RHEUMATIC FEVER 3173
101 DYSPEPSIA 3151
102 COVID-19 3090
103 CONSTIPATION 3087
104 GAIT DISTURBANCE 3086
105 EXPOSURE DURING PREGNANCY 3036
106 MUSCULAR WEAKNESS 2980
107 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2819
108 OVERDOSE 2751
109 OSTEOARTHRITIS 2667
110 INFLAMMATION 2553
111 OEDEMA 2552
112 INJECTION SITE PAIN 2517
113 GASTROOESOPHAGEAL REFLUX DISEASE 2515
114 HYPERHIDROSIS 2445
115 OEDEMA PERIPHERAL 2359
116 DEATH 2347
117 JOINT RANGE OF MOTION DECREASED 2341
118 SWOLLEN JOINT COUNT INCREASED 2335
119 BURSITIS 2320
120 NIGHT SWEATS 2292
121 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2290
122 URINARY TRACT INFECTION 2251
123 BLOOD PRESSURE INCREASED 2230
124 GAIT INABILITY 2200
125 THERAPEUTIC RESPONSE UNEXPECTED 2199
126 DRY SKIN 2172
127 PRODUCT QUALITY ISSUE 2159
128 INCORRECT DOSE ADMINISTERED 2142
129 LUNG DISORDER 2139
130 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2132
131 AMNESIA 2107
132 VISUAL IMPAIRMENT 2085
133 PRESCRIBED OVERDOSE 2060
134 MUSCULOSKELETAL PAIN 2036
135 PALPITATIONS 2036
136 ADVERSE EVENT 2028
137 CHEST DISCOMFORT 2027
138 UPPER RESPIRATORY TRACT INFECTION 1983
139 LIP DRY 1943
140 ADVERSE DRUG REACTION 1937
141 HYPOTENSION 1931
142 HEART RATE INCREASED 1919
143 FACET JOINT SYNDROME 1911
144 MYALGIA 1902
145 ROAD TRAFFIC ACCIDENT 1866
146 WOUND INFECTION 1853
147 OBESITY 1847
148 OROPHARYNGEAL PAIN 1844
149 BRONCHITIS 1834
150 PSORIASIS 1824
151 TREMOR 1819
152 DEHYDRATION 1784
153 C-REACTIVE PROTEIN INCREASED 1780
154 HYPERCHOLESTEROLAEMIA 1746
155 ABDOMINAL DISTENSION 1736
156 TACHYCARDIA 1730
157 ARTHRITIS 1715
158 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1713
159 C-REACTIVE PROTEIN ABNORMAL 1707
160 ANGIOEDEMA 1687
161 ILLNESS 1662
162 INFLUENZA 1652
163 LIVER DISORDER 1646
164 INTENTIONAL PRODUCT MISUSE 1635
165 GRIP STRENGTH DECREASED 1601
166 NASAL CONGESTION 1592
167 BREAST CANCER STAGE III 1573
168 SCIATICA 1570
169 THERAPY NON-RESPONDER 1563
170 ANAPHYLACTIC REACTION 1558
171 ACUTE KIDNEY INJURY 1546
172 PULMONARY FIBROSIS 1527
173 CHILLS 1524
174 KNEE ARTHROPLASTY 1524
175 ANAEMIA 1498
176 LIVE BIRTH 1489
177 NECK PAIN 1481
178 RHINORRHOEA 1466
179 LOWER LIMB FRACTURE 1458
180 HIP ARTHROPLASTY 1449
181 AUTOIMMUNE DISORDER 1445
182 PERIPHERAL VENOUS DISEASE 1431
183 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1426
184 VISION BLURRED 1409
185 FLUSHING 1396
186 CHRONIC KIDNEY DISEASE 1380
187 BLOOD GLUCOSE INCREASED 1367
188 EPILEPSY 1361
189 EAR INFECTION 1357
190 SWELLING FACE 1348
191 LOSS OF CONSCIOUSNESS 1341
192 DEEP VEIN THROMBOSIS POSTOPERATIVE 1338
193 DELIRIUM 1321
194 DRUG INTERACTION 1314
195 INJECTION SITE REACTION 1294
196 DYSPHAGIA 1291
197 FEELING HOT 1286
198 DERMATITIS ATOPIC 1276
199 ECZEMA 1251
200 RENAL FAILURE 1230
201 FLUID RETENTION 1226
202 SEIZURE 1225
203 WITHDRAWAL SYNDROME 1225
204 LIP SWELLING 1213
205 INJECTION SITE ERYTHEMA 1209
206 RASH ERYTHEMATOUS 1208
207 OSTEOPOROSIS 1198
208 HOSPITALISATION 1195
209 DISTURBANCE IN ATTENTION 1189
210 EYE PRURITUS 1187
211 MEDICATION ERROR 1166
212 THERAPEUTIC RESPONSE DECREASED 1166
213 NO ADVERSE EVENT 1155
214 HALLUCINATION 1150
215 CROHN^S DISEASE 1139
216 PRESCRIBED UNDERDOSE 1137
217 TASTE DISORDER 1130
218 THROMBOCYTOPENIA 1126
219 DRUG-INDUCED LIVER INJURY 1119
220 COELIAC DISEASE 1111
221 SKIN EXFOLIATION 1111
222 PRODUCTIVE COUGH 1106
223 STRESS 1104
224 THROAT IRRITATION 1098
225 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1093
226 EAR PAIN 1089
227 BALANCE DISORDER 1080
228 RESPIRATORY DISORDER 1079
229 SYNCOPE 1075
230 DISLOCATION OF VERTEBRA 1073
231 RASH PRURITIC 1073
232 BLEPHAROSPASM 1072
233 NEUROPATHY PERIPHERAL 1041
234 MYOCARDIAL INFARCTION 1038
235 SUICIDAL IDEATION 1017
236 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 985
237 DYSPHONIA 982
238 DRY EYE 980
239 LIVER FUNCTION TEST INCREASED 977
240 UNDERDOSE 976
241 JOINT STIFFNESS 966
242 RED BLOOD CELL SEDIMENTATION RATE INCREASED 965
243 NAIL DISORDER 961
244 COGNITIVE DISORDER 958
245 EPISTAXIS 932
246 TINNITUS 928
247 DYSGEUSIA 913
248 HOT FLUSH 909
249 IMMUNODEFICIENCY 898
250 EXOSTOSIS 893
251 EMOTIONAL DISTRESS 889
252 OXYGEN SATURATION DECREASED 886
253 DRUG DOSE OMISSION 880
254 SEASONAL ALLERGY 878
255 WHITE BLOOD CELL COUNT DECREASED 878
256 EXPIRED PRODUCT ADMINISTERED 874
257 BURNING SENSATION 870
258 MACULAR DEGENERATION 869
259 FOOD ALLERGY 868
260 INJECTION SITE SWELLING 860
261 PULMONARY EMBOLISM 859
262 ACCIDENTAL OVERDOSE 855
263 LARYNGITIS 854
264 HEPATIC CIRRHOSIS 841
265 VERTIGO 841
266 ATRIAL FIBRILLATION 838
267 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 824
268 TOXICITY TO VARIOUS AGENTS 823
269 LUPUS VULGARIS 822
270 PREGNANCY 820
271 INFLUENZA LIKE ILLNESS 817
272 DEPRESSED MOOD 815
273 CEREBROVASCULAR ACCIDENT 809
274 BACK INJURY 806
275 HAEMOGLOBIN DECREASED 798
276 RECTAL HAEMORRHAGE 796
277 ONYCHOMADESIS 778
278 PLATELET COUNT DECREASED 778
279 FOOT DEFORMITY 764
280 EYE SWELLING 763
281 IRRITABILITY 763
282 SEPSIS 759
283 X-RAY ABNORMAL 758
284 COLITIS ULCERATIVE 751
285 FOETAL EXPOSURE DURING PREGNANCY 748
286 EYE IRRITATION 747
287 AGITATION 745
288 MUSCLE TWITCHING 745
289 INJECTION SITE PRURITUS 742
290 LUPUS-LIKE SYNDROME 738
291 JOINT DISLOCATION 733
292 BONE EROSION 728
293 BLOOD PRESSURE DECREASED 724
294 LETHARGY 717
295 TRANSIENT ISCHAEMIC ATTACK 711
296 EYE PAIN 706
297 INJECTION SITE BRUISING 706
298 RETINITIS 702
299 FREQUENT BOWEL MOVEMENTS 697
300 HYPOKALAEMIA 694
301 SWOLLEN TONGUE 692
302 WHITE BLOOD CELL COUNT INCREASED 685
303 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 683
304 OCULAR HYPERAEMIA 682
305 FEBRILE NEUTROPENIA 679
306 SINUS DISORDER 675
307 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 674
308 NEUTROPENIA 670
309 DIABETES MELLITUS 666
310 PAIN OF SKIN 666
311 HEPATITIS 665
312 HERPES ZOSTER 660
313 ALANINE AMINOTRANSFERASE INCREASED 658
314 UNEVALUABLE EVENT 654
315 BODY TEMPERATURE INCREASED 653
316 FLATULENCE 645
317 VIRAL INFECTION 642
318 AGGRESSION 634
319 DIPLOPIA 633
320 DEEP VEIN THROMBOSIS 631
321 SNEEZING 631
322 PANCREATITIS 630
323 ONYCHOMYCOSIS 629
324 THROAT TIGHTNESS 629
325 CATARACT 628
326 DYSPNOEA EXERTIONAL 623
327 RASH MACULAR 622
328 CELLULITIS 617
329 DISEASE RECURRENCE 617
330 DRUG ABUSE 615
331 BONE PAIN 613
332 DRUG DEPENDENCE 611
333 ACCIDENTAL EXPOSURE TO PRODUCT 608
334 DISABILITY 606
335 ANOSMIA 602
336 BLINDNESS 602
337 NEPHROLITHIASIS 599
338 ACNE 595
339 LACRIMATION INCREASED 595
340 HAEMATOCHEZIA 594
341 EXTRA DOSE ADMINISTERED 588
342 SKIN BURNING SENSATION 587
343 FACIAL PAIN 583
344 PLEURAL EFFUSION 583
345 THROMBOSIS 580
346 MIDDLE INSOMNIA 579
347 C-REACTIVE PROTEIN 576
348 HAEMORRHAGE 575
349 PRURITUS GENERALISED 574
350 ASPARTATE AMINOTRANSFERASE INCREASED 572
351 PARAESTHESIA ORAL 572
352 CARDIAC FAILURE CONGESTIVE 571
353 WALKING AID USER 571
354 CARDIAC DISORDER 569
355 NERVOUSNESS 569
356 CRYING 557
357 SLEEP APNOEA SYNDROME 555
358 THERAPY INTERRUPTED 552
359 RASH PAPULAR 546
360 THERAPEUTIC RESPONSE SHORTENED 545
361 SLEEP TERROR 540
362 SURGERY 537
363 DISEASE PROGRESSION 536
364 GASTROENTERITIS VIRAL 535
365 BREAST CANCER STAGE II 534
366 RENAL IMPAIRMENT 533
367 RESPIRATORY TRACT INFECTION 531
368 SKIN DISCOLOURATION 527
369 PANIC ATTACK 524
370 NIGHTMARE 522
371 FINGER DEFORMITY 516
372 RESPIRATORY FAILURE 514
373 CONGENITAL ANOMALY 509
374 PRODUCT SUBSTITUTION ISSUE 508
375 SUBARACHNOID HAEMORRHAGE 505
376 BLOOD CREATININE INCREASED 503
377 ANGER 496
378 COLITIS 496
379 DYSURIA 494
380 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 491
381 SPEECH DISORDER 490
382 VASCULITIS 490
383 DRUG EFFECT INCOMPLETE 488
384 DEVICE ISSUE 485
385 DRUG TOLERANCE DECREASED 485
386 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 484
387 LYMPHADENOPATHY 484
388 SKIN LESION 484
389 HYPONATRAEMIA 483
390 VENTRICULAR TACHYCARDIA 483
391 HYPERSOMNIA 482
392 TEMPERATURE REGULATION DISORDER 482
393 GASTROINTESTINAL HAEMORRHAGE 478
394 INJECTION SITE HAEMORRHAGE 478
395 FUNGAL INFECTION 477
396 LIMB DISCOMFORT 477
397 PROCEDURAL PAIN 477
398 INFUSION SITE PAIN 474
399 MUSCLE SPASTICITY 474
400 THERAPY CESSATION 474
401 DRUG WITHDRAWAL SYNDROME 473
402 POLLAKIURIA 463
403 CHRONIC SINUSITIS 457
404 OBSTRUCTIVE AIRWAYS DISORDER 457
405 TENSION HEADACHE 454
406 ADVERSE REACTION 452
407 ADRENAL INSUFFICIENCY 450
408 PRODUCT DOSE OMISSION 447
409 PRURITUS GENITAL 447
410 ABNORMAL BEHAVIOUR 445
411 LABORATORY TEST ABNORMAL 445
412 PRODUCT DOSE OMISSION IN ERROR 442
413 CARDIAC ARREST 441
414 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 439
415 DISORIENTATION 438
416 BLOOD POTASSIUM DECREASED 437
417 DYSARTHRIA 437
418 PRODUCT LABEL CONFUSION 434
419 TREATMENT NONCOMPLIANCE 431
420 SINUS CONGESTION 429
421 HEART RATE DECREASED 423
422 BLOOD PRESSURE SYSTOLIC INCREASED 420
423 RETCHING 417
424 CHOLELITHIASIS 416
425 ATRIAL TACHYCARDIA 414
426 DRUG EFFECT DECREASED 414
427 MATERNAL EXPOSURE TIMING UNSPECIFIED 412
428 CARDIAC FAILURE 410
429 CAROTID ARTERY OCCLUSION 410
430 BRADYCARDIA 409
431 SUICIDE ATTEMPT 408
432 BACK DISORDER 407
433 HYPOXIA 404
434 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 403
435 EYE DISORDER 403
436 SKIN IRRITATION 403
437 CARDIOSPASM 402
438 ULCER HAEMORRHAGE 402
439 MULTIPLE SCLEROSIS 400
440 CYSTITIS 397
441 HEAD INJURY 397
442 SKIN DISORDER 397
443 MOOD SWINGS 395
444 SCRATCH 395
445 RESTLESSNESS 393
446 PALMOPLANTAR KERATODERMA 389
447 JOINT INJURY 387
448 MULTIPLE SCLEROSIS RELAPSE 387
449 LEUKOPENIA 386
450 MULTIPLE ALLERGIES 385
451 CONVULSION 384
452 HEREDITARY ANGIOEDEMA 384
453 POOR QUALITY SLEEP 382
454 CONJUNCTIVITIS 381
455 IMPAIRED QUALITY OF LIFE 379
456 INTERVERTEBRAL DISC PROTRUSION 378
457 LIMB INJURY 378
458 STAPHYLOCOCCAL INFECTION 376
459 INTENTIONAL OVERDOSE 375
460 SKIN FISSURES 375
461 ORAL CANDIDIASIS 370
462 URINARY RETENTION 370
463 INJECTION SITE RASH 368
464 INTENTIONAL DOSE OMISSION 368
465 BLOOD PRESSURE FLUCTUATION 365
466 MENTAL DISORDER 365
467 DEVICE MALFUNCTION 364
468 MOOD ALTERED 363
469 URINARY INCONTINENCE 363
470 ANHEDONIA 357
471 RED BLOOD CELL COUNT DECREASED 357
472 GASTRITIS 355
473 PAIN IN JAW 351
474 INFUSION SITE REACTION 349
475 SERONEGATIVE ARTHRITIS 349
476 ORAL PAIN 347
477 DIVERTICULITIS 343
478 PANCYTOPENIA 343
479 BRAIN FOG 342
480 DRUG ADMINISTRATION ERROR 342
481 FEELING COLD 341
482 PRESYNCOPE 341
483 DRUG TOLERANCE 337
484 RENAL DISORDER 336
485 INJECTION SITE URTICARIA 334
486 HYPOGLYCAEMIA 333
487 CYTOKINE RELEASE SYNDROME 332
488 RESPIRATORY TRACT CONGESTION 331
489 RESTLESS LEGS SYNDROME 327
490 TEMPERATURE INTOLERANCE 326
491 AGEUSIA 325
492 PHOTOPHOBIA 325
493 PULMONARY OEDEMA 324
494 END STAGE RENAL DISEASE 323
495 DERMATITIS CONTACT 322
496 DYSKINESIA 321
497 COMPLETED SUICIDE 319
498 PHARYNGEAL SWELLING 319
499 SEPTIC SHOCK 319
500 SKIN HAEMORRHAGE 319
501 ANAPHYLACTIC SHOCK 318
502 ABNORMAL DREAMS 317
503 ORAL HERPES 316
504 FEELING JITTERY 314
505 ABORTION SPONTANEOUS 313
506 HYPOTHYROIDISM 312
507 RASH GENERALISED 310
508 INFUSION SITE ERYTHEMA 309
509 ARRHYTHMIA 308
510 MALIGNANT NEOPLASM PROGRESSION 308
511 WEIGHT FLUCTUATION 308
512 EOSINOPHILIA 307
513 ELECTROCARDIOGRAM QT PROLONGED 306
514 FOETAL DEATH 305
515 FEAR 304
516 EMOTIONAL DISORDER 303
517 BLOOD GLUCOSE DECREASED 302
518 INTESTINAL OBSTRUCTION 302
519 PSYCHOMOTOR HYPERACTIVITY 302
520 COMA 301
521 NEURALGIA 301
522 APHASIA 299
523 UPPER-AIRWAY COUGH SYNDROME 299
524 HAEMOPTYSIS 298
525 VAGINAL HAEMORRHAGE 298
526 DERMATITIS 296
527 ULCER 293
528 COORDINATION ABNORMAL 292
529 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 292
530 MYOSITIS 291
531 WRONG PATIENT RECEIVED MEDICATION 291
532 INFUSION SITE SWELLING 290
533 INSURANCE ISSUE 290
534 MOVEMENT DISORDER 290
535 RASH VESICULAR 290
536 INJECTION SITE MASS 289
537 RASH MACULO-PAPULAR 287
538 DYSSTASIA 286
539 PORPHYRIA ACUTE 286
540 VITAMIN D DEFICIENCY 285
541 GASTRIC DISORDER 284
542 INCORRECT PRODUCT ADMINISTRATION DURATION 284
543 HEART RATE IRREGULAR 282
544 MUCOSAL INFLAMMATION 281
545 HYPOACUSIS 280
546 PHARYNGITIS STREPTOCOCCAL 280
547 PHOTOSENSITIVITY REACTION 280
548 BLOOD ALKALINE PHOSPHATASE INCREASED 278
549 HYPERGLYCAEMIA 276
550 THINKING ABNORMAL 275
551 LYMPHOCYTE COUNT DECREASED 274
552 PRE-EXISTING CONDITION IMPROVED 274
553 RHINITIS 274
554 GALLBLADDER DISORDER 272
555 SEDATION 271
556 FOOT FRACTURE 270
557 CLOSTRIDIUM DIFFICILE INFECTION 269
558 JAUNDICE 269
559 HEAD DISCOMFORT 267
560 OSTEOPENIA 267
561 PRODUCT ADMINISTRATION ERROR 266
562 PHARYNGEAL OEDEMA 265
563 RENAL INJURY 264
564 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 263
565 VAGINAL DISCHARGE 262
566 IMMUNISATION 259
567 MOUTH ULCERATION 259
568 CORONARY ARTERY DISEASE 257
569 NEUTROPHIL COUNT DECREASED 257
570 RHINITIS ALLERGIC 255
571 SECRETION DISCHARGE 254
572 CHROMATURIA 253
573 HAEMATOCRIT DECREASED 253
574 HAEMORRHOIDS 252
575 IMPAIRED WORK ABILITY 252
576 HYPERKALAEMIA 251
577 APHONIA 250
578 MUSCULOSKELETAL DISCOMFORT 250
579 POST-TRAUMATIC STRESS DISORDER 250
580 PHARYNGITIS 249
581 INTERSTITIAL LUNG DISEASE 248
582 NORMAL NEWBORN 248
583 HYPOAESTHESIA ORAL 247
584 NODULE 246
585 CANDIDA INFECTION 244
586 RESPIRATORY DISTRESS 244
587 TOOTH DISORDER 243
588 CARPAL TUNNEL SYNDROME 242
589 PNEUMONITIS 242
590 SCAR 240
591 KIDNEY INFECTION 239
592 PUSTULAR PSORIASIS 239
593 BREAST CANCER 238
594 HIATUS HERNIA 237
595 IMPAIRED GASTRIC EMPTYING 237
596 PALLOR 237
597 SKIN PLAQUE 237
598 CHOKING 236
599 LOCALISED INFECTION 235
600 ACUTE RESPIRATORY FAILURE 234
601 RIB FRACTURE 234
602 ROTATOR CUFF SYNDROME 234
603 HEPATIC STEATOSIS 233
604 PRODUCT ADMINISTRATION INTERRUPTED 233
605 NEOPLASM MALIGNANT 232
606 SKIN REACTION 232
607 SPONDYLITIS 232
608 TENDERNESS 231
609 PRODUCT PHYSICAL ISSUE 230
610 SKIN ULCER 230
611 SPUTUM DISCOLOURED 230
612 BRONCHOSPASM 229
613 NEEDLE ISSUE 229
614 WRONG DRUG ADMINISTERED 229
615 PHARMACEUTICAL PRODUCT COMPLAINT 228
616 BLOOD SODIUM DECREASED 227
617 CHRONIC SPONTANEOUS URTICARIA 227
618 DEVICE DISLOCATION 227
619 THIRST 226
620 BLOOD UREA INCREASED 224
621 POLYARTHRITIS 224
622 PRODUCT STORAGE ERROR 224
623 STEVENS-JOHNSON SYNDROME 224
624 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 224
625 TOOTH FRACTURE 224
626 JOINT DESTRUCTION 223
627 BLOOD URINE PRESENT 222
628 INCREASED APPETITE 222
629 MUSCLE TIGHTNESS 222
630 MYDRIASIS 222
631 PRODUCT AVAILABILITY ISSUE 219
632 DRUG EXPOSURE DURING PREGNANCY 218
633 ECONOMIC PROBLEM 218
634 LIVER FUNCTION TEST ABNORMAL 218
635 PULMONARY HYPERTENSION 218
636 RADICULOPATHY 218
637 GENERAL SYMPTOM 217
638 SKIN INFECTION 217
639 DRUG DOSE OMISSION BY DEVICE 216
640 EXPOSURE VIA SKIN CONTACT 216
641 UPPER LIMB FRACTURE 216
642 FEEDING DISORDER 215
643 PULMONARY MASS 212
644 EATING DISORDER 211
645 HYPOPHAGIA 210
646 GASTROENTERITIS 209
647 HIP FRACTURE 209
648 HYPOCALCAEMIA 208
649 FACE OEDEMA 207
650 MUSCULOSKELETAL CHEST PAIN 207
651 PRODUCT PACKAGING ISSUE 207
652 CHOLECYSTITIS CHRONIC 205
653 FLANK PAIN 203
654 PROCTITIS 203
655 ANKLE FRACTURE 202
656 DERMATITIS ALLERGIC 202
657 BLOOD IMMUNOGLOBULIN E INCREASED 201
658 PARANOIA 201
659 SPINAL FUSION SURGERY 201
660 TENDONITIS 201
661 TOOTHACHE 201
662 SENSORY DISTURBANCE 200
663 GOUT 199
664 HALLUCINATION, VISUAL 199
665 INJECTION SITE WARMTH 199
666 NEPHROGENIC ANAEMIA 199
667 HAEMATURIA 198
668 INITIAL INSOMNIA 198
669 ANGINA PECTORIS 197
670 INTERVERTEBRAL DISC DEGENERATION 197
671 OROPHARYNGEAL DISCOMFORT 197
672 DRUG EFFECT LESS THAN EXPECTED 196
673 INFUSION SITE PRURITUS 196
674 CARDIO-RESPIRATORY ARREST 195
675 FULL BLOOD COUNT ABNORMAL 194
676 HAEMATOMA 194
677 PANCREATITIS ACUTE 194
678 BLOOD IRON DECREASED 192
679 FAECES DISCOLOURED 192
680 MENTAL STATUS CHANGES 192
681 SCAB 192
682 DEVICE BREAKAGE 191
683 HYPERLIPIDAEMIA 191
684 BLOOD TEST ABNORMAL 190
685 EOSINOPHIL COUNT INCREASED 190
686 FULL BLOOD COUNT DECREASED 190
687 GLAUCOMA 190
688 DEMENTIA 189
689 DEPRESSED LEVEL OF CONSCIOUSNESS 189
690 EYE INJURY 188
691 FORCED EXPIRATORY VOLUME DECREASED 188
692 POST PROCEDURAL COMPLICATION 188
693 PULMONARY CONGESTION 188
694 WRONG TECHNIQUE IN DRUG USAGE PROCESS 188
695 ABDOMINAL PAIN LOWER 187
696 ACUTE MYOCARDIAL INFARCTION 187
697 BONE DENSITY DECREASED 187
698 BONE DISORDER 187
699 FEMALE GENITAL TRACT FISTULA 187
700 EAR DISCOMFORT 186
701 TOOTH INFECTION 186
702 TUBULOINTERSTITIAL NEPHRITIS 186
703 CYSTIC FIBROSIS 185
704 DRY THROAT 185
705 MASS 185
706 QUALITY OF LIFE DECREASED 185
707 RHABDOMYOLYSIS 185
708 SARS-COV-2 TEST POSITIVE 185
709 ARTHROPOD BITE 184
710 BLOOD PRESSURE ABNORMAL 184
711 NASAL DRYNESS 184
712 PLASMA CELL MYELOMA 184
713 SPINAL OSTEOARTHRITIS 184
714 BACTERIAL INFECTION 183
715 PRODUCT TASTE ABNORMAL 182
716 BLOOD COUNT ABNORMAL 181
717 DEAFNESS 181
718 NERVOUS SYSTEM DISORDER 181
719 RENAL FAILURE ACUTE 181
720 SLUGGISHNESS 181
721 TOOTH ABSCESS 181
722 APLASTIC ANAEMIA 180
723 GINGIVAL BLEEDING 180
724 COLD SWEAT 178
725 PNEUMONIA ASPIRATION 178
726 PSYCHOTIC DISORDER 177
727 UNRESPONSIVE TO STIMULI 177
728 BLOOD TRIGLYCERIDES INCREASED 176
729 INFUSION SITE HAEMORRHAGE 176
730 VISUAL ACUITY REDUCED 176
731 CARDIOMEGALY 175
732 BLOOD BILIRUBIN INCREASED 174
733 SINUS HEADACHE 174
734 HYPOMAGNESAEMIA 173
735 PERICARDIAL EFFUSION 173
736 SOMNAMBULISM 173
737 HAIR COLOUR CHANGES 172
738 PRODUCT LABEL ISSUE 172
739 VAGINAL FLATULENCE 172
740 ATELECTASIS 171
741 DRUG ERUPTION 171
742 SINUS TACHYCARDIA 171
743 SPINAL DISORDER 171
744 THERAPY PARTIAL RESPONDER 171
745 ACTIVITIES OF DAILY LIVING IMPAIRED 170
746 BODY TEMPERATURE DECREASED 170
747 GLYCOSYLATED HAEMOGLOBIN INCREASED 170
748 MENTAL IMPAIRMENT 169
749 PELVIC PAIN 168
750 LIGAMENT SPRAIN 167
751 DRUG USE DISORDER 166
752 ORTHOSTATIC HYPOTENSION 166
753 EYE INFECTION 165
754 HERNIA 165
755 INTENTIONAL SELF-INJURY 165
756 MAST CELL ACTIVATION SYNDROME 165
757 PERIORBITAL SWELLING 165
758 DECREASED ACTIVITY 164
759 ERUCTATION 164
760 FEMUR FRACTURE 164
761 HAIR TEXTURE ABNORMAL 164
762 THYROID DISORDER 164
763 DEATH NEONATAL 163
764 POOR VENOUS ACCESS 163
765 SKIN LACERATION 163
766 BASAL CELL CARCINOMA 162
767 BLOOD PRESSURE DIASTOLIC DECREASED 162
768 BLOOD CALCIUM DECREASED 161
769 INCORRECT DRUG ADMINISTRATION DURATION 161
770 INFUSION SITE EXTRAVASATION 161
771 MITRAL VALVE INCOMPETENCE 161
772 PRODUCT PRESCRIBING ERROR 160
773 MANIA 159
774 SPINAL FRACTURE 159
775 TOXIC EPIDERMAL NECROLYSIS 159
776 PLATELET COUNT INCREASED 158
777 RESPIRATORY SYNCYTIAL VIRUS INFECTION 158
778 DEVICE LEAKAGE 157
779 MENSTRUATION IRREGULAR 157
780 DEVICE EXPULSION 156
781 HUNGER 156
782 LOCAL SWELLING 155
783 SWELLING OF EYELID 155
784 BODY HEIGHT DECREASED 154
785 CHOLECYSTECTOMY 154
786 MOUTH SWELLING 154
787 ORAL DISCOMFORT 154
788 PARKINSON^S DISEASE 154
789 PERIPHERAL COLDNESS 154
790 CONCUSSION 153
791 NEUTROPHIL COUNT INCREASED 153
792 PAPULE 153
793 PARANASAL SINUS DISCOMFORT 153
794 PRODUCT USE COMPLAINT 153
795 EYE DISCHARGE 152
796 APPLICATION SITE ERYTHEMA 151
797 CHOLECYSTITIS 151
798 DYSTONIA 151
799 HAEMATEMESIS 151
800 PULMONARY PAIN 151
801 DEVICE DELIVERY SYSTEM ISSUE 150
802 NOCTURIA 150
803 PETECHIAE 150
804 COVID-19 PNEUMONIA 149
805 BLOOD MAGNESIUM DECREASED 148
806 CEREBRAL HAEMORRHAGE 148
807 DRUG PRESCRIBING ERROR 148
808 FEELING DRUNK 148
809 GASTRIC ULCER 148
810 GASTROINTESTINAL PAIN 148
811 IRON DEFICIENCY ANAEMIA 148
812 ASPIRATION 147
813 OCULAR DISCOMFORT 147
814 PULMONARY ARTERIAL HYPERTENSION 147
815 PULMONARY FUNCTION TEST DECREASED 147
816 SENSATION OF FOREIGN BODY 147
817 SENSITIVITY TO WEATHER CHANGE 147
818 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 146
819 APPLICATION SITE PRURITUS 146
820 ERECTILE DYSFUNCTION 146
821 IMMUNE SYSTEM DISORDER 145
822 LUNG NEOPLASM MALIGNANT 145
823 NASAL DISCOMFORT 145
824 OSTEONECROSIS 145
825 PRODUCT DISTRIBUTION ISSUE 145
826 SYMPTOM RECURRENCE 145
827 DENTAL CARIES 144
828 HEPATIC FAILURE 144
829 BRONCHIECTASIS 143
830 ENCEPHALOPATHY 143
831 INCREASED TENDENCY TO BRUISE 143
832 TARDIVE DYSKINESIA 143
833 VITAMIN D DECREASED 143
834 CYANOSIS 142
835 DECREASED IMMUNE RESPONSIVENESS 142
836 HEPATOCELLULAR INJURY 142
837 DEMYELINATION 141
838 GAMMA-GLUTAMYLTRANSFERASE INCREASED 141
839 NEOPLASM PROGRESSION 141
840 SNORING 141
841 BLOOD POTASSIUM INCREASED 140
842 DEVICE RELATED INFECTION 140
843 LEUKOCYTOSIS 140
844 MICTURITION URGENCY 140
845 ALTERED STATE OF CONSCIOUSNESS 139
846 OBSESSIVE-COMPULSIVE DISORDER 139
847 OSTEOMYELITIS 139
848 SWOLLEN JOINT COUNT 139
849 MATERNAL EXPOSURE BEFORE PREGNANCY 138
850 ORAL PRURITUS 138
851 SKIN CANCER 138
852 WRIST FRACTURE 138
853 ASCITES 137
854 GENERALISED TONIC-CLONIC SEIZURE 137
855 INFUSION SITE DISCHARGE 137
856 MUSCULOSKELETAL DISORDER 137
857 SKIN SWELLING 137
858 MENORRHAGIA 136
859 SKIN WARM 136
860 ACCIDENT 135
861 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 135
862 GRIP STRENGTH 135
863 DIZZINESS POSTURAL 134
864 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 134
865 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 134
866 HYPOKINESIA 133
867 MONOCYTE COUNT INCREASED 133
868 VENTRICULAR EXTRASYSTOLES 133
869 BLOOD PRESSURE DIASTOLIC INCREASED 132
870 EMPHYSEMA 132
871 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 132
872 SMALL INTESTINAL OBSTRUCTION 132
873 AFFECTIVE DISORDER 131
874 CYST 131
875 HEMIPARESIS 131
876 RESPIRATORY RATE INCREASED 131
877 CARDIAC MURMUR 130
878 CHOLESTASIS 130
879 MADAROSIS 130
880 COMPLICATION ASSOCIATED WITH DEVICE 129
881 GLOMERULAR FILTRATION RATE DECREASED 129
882 HEPATIC FUNCTION ABNORMAL 129
883 PSYCHOLOGICAL TRAUMA 129
884 ABSCESS 128
885 DEVICE USE ERROR 128
886 NERVE COMPRESSION 128
887 OVARIAN CYST 128
888 INTERNATIONAL NORMALISED RATIO INCREASED 127
889 INTERVERTEBRAL DISCITIS 127
890 PARALYSIS 127
891 PRODUCT PRESCRIBING ISSUE 127
892 ABASIA 126
893 VITAMIN B12 DEFICIENCY 126
894 BLOOD CREATINE PHOSPHOKINASE INCREASED 125
895 FRUSTRATION TOLERANCE DECREASED 125
896 DIABETES MELLITUS INADEQUATE CONTROL 124
897 GINGIVAL PAIN 124
898 INFUSION SITE BRUISING 124
899 OVERLAP SYNDROME 124
900 REBOUND ACID HYPERSECRETION 124
901 RHINOVIRUS INFECTION 124
902 DYSMENORRHOEA 123
903 HYPERPARATHYROIDISM SECONDARY 123
904 INJECTION SITE DISCOLOURATION 123
905 STREPTOCOCCAL INFECTION 123
906 TIC 123
907 BREAST MASS 122
908 RESPIRATORY ARREST 122
909 SUPRAVENTRICULAR TACHYCARDIA 122
910 APPETITE DISORDER 121
911 CHOLECYSTITIS ACUTE 121
912 EYELID OEDEMA 121
913 LACTIC ACIDOSIS 121
914 MUSCLE STRAIN 121
915 PAROSMIA 121
916 REBOUND EFFECT 121
917 SPINAL OPERATION 121
918 TENDON DISORDER 121
919 BIPOLAR DISORDER 120
920 BREATH SOUNDS ABNORMAL 120
921 IMPAIRED DRIVING ABILITY 120
922 GENERALISED OEDEMA 119
923 JOINT EFFUSION 119
924 METRORRHAGIA 119
925 OSTEONECROSIS OF JAW 119
926 PNEUMOTHORAX 119
927 TRANSAMINASES INCREASED 119
928 APPLICATION SITE PAIN 118
929 DRUG DISPENSING ERROR 118
930 ELECTRIC SHOCK 118
931 FOOD POISONING 118
932 POISONING 118
933 PROCTALGIA 118
934 URINE ABNORMALITY 118
935 DELUSION 117
936 DIVERTICULUM 117
937 HEPATOTOXICITY 117
938 NERVE INJURY 117
939 SENSITIVE SKIN 117
940 TRICUSPID VALVE INCOMPETENCE 117
941 HAIR DISORDER 116
942 SKIN ABRASION 116
943 THROAT CLEARING 116
944 DIABETIC KETOACIDOSIS 115
945 FORMICATION 115
946 MAJOR DEPRESSION 115
947 METABOLIC ACIDOSIS 115
948 SJOGREN^S SYNDROME 115
949 UROSEPSIS 115
950 GASTROINTESTINAL INFECTION 114
951 INJECTION SITE INDURATION 114
952 PRODUCT DISPENSING ERROR 114
953 TOOTH EXTRACTION 114
954 WRONG PRODUCT ADMINISTERED 114
955 FOOT OPERATION 113
956 MENISCUS INJURY 113
957 ORAL DISORDER 113
958 TACHYPNOEA 113
959 HYSTERECTOMY 112
960 MELAENA 112
961 APATHY 111
962 DEVICE FAILURE 111
963 LYMPHOPENIA 111
964 BRUXISM 110
965 EJECTION FRACTION DECREASED 110
966 ATTENTION DEFICIT HYPERACTIVITY DISORDER 109
967 CIRCULATORY COLLAPSE 109
968 PRODUCT COMPLAINT 109
969 PSEUDOMONAS INFECTION 109
970 RESPIRATION ABNORMAL 109
971 SPLENOMEGALY 109
972 SUSPECTED OFF LABEL USE 109
973 HALLUCINATION, AUDITORY 108
974 RENAL CYST 108
975 ERYTHEMA MULTIFORME 107
976 NASAL POLYPS 107
977 SYNOVIAL CYST 107
978 WHITE BLOOD CELLS URINE POSITIVE 107
979 PRODUCT PREPARATION ERROR 106
980 PURPURA 106
981 RALES 106
982 ENDOMETRIOSIS 105
983 KNEE OPERATION 105
984 OESOPHAGITIS 105
985 PRODUCT ADHESION ISSUE 105
986 SINUS BRADYCARDIA 105
987 SKIN WEEPING 105
988 TENDON RUPTURE 105
989 TONGUE DISORDER 105
990 TOOTH LOSS 105
991 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 104
992 HYPERTRANSAMINASAEMIA 104
993 HYPOCHOLESTEROLAEMIA 104
994 TRANSFUSION 104
995 BLOOD GLUCOSE ABNORMAL 103
996 CORONARY ARTERY OCCLUSION 103
997 EYE INFLAMMATION 103
998 INJECTION SITE IRRITATION 103
999 MULTIPLE ORGAN DYSFUNCTION SYNDROME 103